Stock researchfirms currently have a positive stance on shares of athenahealth, Inc. (NASDAQ:ATHN). Analysts are projecting that the stock will reach $133.65 on a short term (1 year) basis.

The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.30. This is based on the research brokerage reports taken into consideration by Thomson Reuters.

athenahealth, Inc. (NASDAQ:ATHN)s shares may have a significant upside to the consensus target of133.65, but how has it been performing relative to the market? The stocks price is 145.36 and their relative strength index (RSI) stands at 69.85. RSI is a technical oscillator that shows price strength by comparing upward and downward movements. It indicates oversold and overbought price levels for a stock.

athenahealth, Inc. (NASDAQ:ATHN) shares are moving2.64% trading at $145.36 today.

Brokerage firms currently have a positive stance on shares of CRISPR Therapeutics AG (:CRSP). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.00. Those same analysts are projecting that the stock will reach $23.70 on a short term basis.

Performance At the time of writing, the stock was trading at $14.81. This represents a change from most recent open price of 2.63%. In terms of performance, year to date, the stock is -26.90%. The monthly stock performance comes in at -4.51%. For the quarter, shares are performing at -28.63%. Weekly performance analysis shows the equity at 1.44%.

Technicals In taking a look at technical levels, shares are trading -9.95% away from the 50 day simple moving average and -19.49% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -40.76% away from its 52- week high and 27.34% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, CRISPR Therapeutics AGs RSI stands at 45.44. In looking at volatility levels, the shares saw weekly volatility of 4.16% and 4.84% over the past month.

By DR Staff Writer

Follow this link:

Target Price Updates on athenahealth, Inc. (NASDAQ:ATHN ... - Davidson Register

Comments are closed.